| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,135,000 | 6,809,000 | 6,945,000 | 12,306,000 | | Cost of Revenue | 3,924,000 | 3,841,000 | 3,880,000 | 7,092,000 | | | Gross Profit | 3,211,000 | 2,968,000 | 3,065,000 | 5,214,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,612,000 | 1,598,000 | 1,652,000 | 2,794,000 | | Non Recurring | 63,000 | 75,000 | 94,000 | 24,405,000 | | Others | 115,000 | 112,000 | 121,000 | 201,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,388,000 | 1,183,000 | 1,198,000 | (22,186,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (84,000) | 19,000 | (39,000) | (354,000) | | Earnings Before Interest And Taxes | 433,000 | 1,202,000 | 1,159,000 | (20,300,000) | | Interest Expense | (607,000) | 295,000 | 312,000 | 644,000 | | Income Before Tax | 1,040,000 | 907,000 | 847,000 | (20,944,000) | | Income Tax Expense | 377,000 | 377,000 | 288,000 | (4,910,000) | | Minority Interest |
-
|
-
|
-
| 2,240,000 | | | | Net Income From Continuing Ops | 663,000 | 530,000 | 559,000 | (16,034,000) | | | Non-recurring Events | | Discontinued Operations | (1,000) |
-
| 131,000 | 2,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 621,000 | 530,000 | 690,000 | (16,032,000) | | Preferred Stock And Other Adjustments | 40,000 | (11,000) | (29,000) |
-
| | | Net Income Applicable To Common Shares | $661,000 | $519,000 | $661,000 | ($16,032,000) |
|
0.20% Nasdaq 
0.14%
Income Statement
